Scientists move HIV vaccine research forward by developing an immunogen that produces tier-2 antibodies
Scientists take a promising step in the direction of developing an HIV vaccine using a unique native-like trimer to develop Tier-2 neutralizing antibodies — the kind that matter for combating HIV — in mice.
Materials provided by The Wistar Institute. Note: Content may be edited for style and length.
Source link aaaaa